Interview with Scandion Oncology
08 October 2020 - 11:32Interview with Scandion Oncology CSO Nils Brünner during the cancer research day at Penser Bank....
Scandion Oncology A/S
Scandion Oncology A/S is a biotechnology company with the mission to address one of the most important challenges in modern oncology - the effective treatment of cancer which has developed resistance towards existing cancer medicine. Its first-in-class lead compound, SCO-101, is an add-on to chemotherapy and is currently in clinical phase I and II studies in cancer patients. The company also has s...Learn more about company